Golden Green’s Jazz Pharmaceuticals JAZZ Stock Holding History

Golden Green’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,236	Closed	-$356K	–	83
2022 Q4	$356K	Sell	2,236 -28	-1%	-$4.1K	0.37%	61
2022 Q3	$302K	Buy	2,264 +962	+74%	+$146K	0.33%	62
2022 Q2	$203K	Sell	1,302 -603	-32%	-$92.8K	0.21%	61
2022 Q1	$297K	Buy	+1,905	New	+$276K	0.24%	67
2021 Q3	–	Sell	-1,342	Closed	-$238K	–	159
2021 Q2	$238K	Hold	1,342	–	–	0.18%	134
2021 Q1	$221K	Hold	1,342	–	–	0.19%	145
2020 Q4	$221K	Buy	+1,342	New	+$200K	0.21%	100

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Golden Green's JAZZ Position: Q1 2023 in Review

Golden Green sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2023, closing a stake of 2,236 shares — an estimated $356K sold.

Golden Green first reported a position in JAZZ in Q4 2020 and held it in 7 quarters. The position peaked at $356K in Q4 2022. 471 funds tracked by Wall St. Rank hold JAZZ as of Q1 2023.

Golden Green reported no remaining Jazz Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
Golden Green sold 2,236 Jazz Pharmaceuticals shares in Q1 2023, an estimated $356K.
Golden Green first reported a position in Jazz Pharmaceuticals in Q4 2020 and held it in 7 quarters.
Golden Green's Jazz Pharmaceuticals position peaked at $356K in Q4 2022.
471 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2023.

Based on Golden Green's 13F filing for Q1 2023, filed 11 May 2023.